A081105 Alchemist / EGFR positive, study of Erlotinib vs Observation/ Yuhchyau ChenResearch Question:
Does erlotinib treat patients with non-small cell lung cancer?
Basic Study Information
Purpose:Location: Highland Hospital
This phase III ALCHEMIST trial studies how well erlotinib hydrochloride compared to
observation works in treating patients with stage IB-IIIA non-small cell lung cancer
that has been completely removed by surgery. Erlotinib hydrochloride may stop the
growth of tumor cells by blocking some of the enzymes needed for cell growth.
Lead Researcher (Principal Investigator)
Study Contact Information
Additional Study Details
Trial Not Found
The study you are looking for is not active at this time.
Return to Search